ONMD ONMD
Company Profile ↓Company Overview
ONMD (ONMD) is a publicly traded company listed on with a market capitalization of $33.91M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 94.5%, reflecting efficient use of shareholder capital.
Recent Developments
- Dec 2025 Revenue of $1.36M (+111.4% YoY); net profit $-2.80M.
- Trailing 12 Months Year-on-year growth — revenue +111.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 5.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 5.63% |
| 1 Year: | 111.35% |
Stock Price Performance
| 1 Year: | +30.93% |
| 6 Months: | -17.67% |
| 3 Months: | -35.19% |
| 1 Month: | -9.21% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.90 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 94.5%.
CONS
- Trading 79.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 200.00K | 173.00K | 326.00K | 248.00K | 227.00K | 142.00K | - | 137.00K | 155.00K | 177.00K | 891.00K | 96.00K |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 361.00K | 396.00K | 399.00K | 726.00K | 476.00K |
| Gross Profit | - | - | - | - | - | -89.00K | -57.00K | 33.00K | -69.00K | -102.00K | -84.00K | - | -224.00K | -241.00K | -222.00K | 165.00K | -380.00K |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 2.00M | 1.82M | 2.01M | 3.25M | 2.17M |
| Operating Income | -70.49K | -98.72K | -610.18K | -794.50K | -520.02K | -1.47M | -1.57M | -1.93M | -2.10M | -2.45M | -2.34M | - | -2.22M | -2.06M | -2.23M | -3.08M | -2.55M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | -1.86M | 3.04M | -725.00K | -3.12M | -2.43M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | 31.00K | 22.00K | 6.00K | 8.00K | 10.00K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | -1.90M | 2.98M | -741.00K | -3.14M | -2.45M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | 4.31M | 1.29M | 2.20M | 949.94K | -153.28K | -7.84M | -9.60M | -13.84M | -2.11M | -3.59M | -2.06M | - | -1.90M | 2.98M | -741.00K | -3.14M | -2.45M |
| Diluted EPS | - | - | - | - | - | -1.94 | -2.38 | -3.23 | -0.08 | -0.14 | -0.07 | - | -0.06 | 0.07 | -0.01 | - | -0.04 |
| R&D Expense | - | - | - | - | - | 582.00K | 579.00K | 405.00K | 445.00K | 383.00K | 298.00K | - | 348.00K | 382.00K | 323.00K | - | 311.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 1.15M | 1.02M | 643.00K | 1.36M |
| Cost of Revenue | - | 1.51M | 1.15M | 924.00K | 1.86M |
| Gross Profit | - | -360.00K | -129.00K | -281.00K | -503.00K |
| Operating Expenses | - | 15.43M | 6.72M | 9.32M | 9.16M |
| Operating Income | - | -15.79M | -6.85M | -9.61M | -9.67M |
| EBITDA | - | -30.41M | -33.72M | -9.92M | -2.67M |
| Interest Expense | - | 0 | 11.00K | 147.00K | 67.00K |
| Pretax Income | - | -30.43M | -33.76M | -10.13M | -2.80M |
| Tax Provision | - | 17.00K | 18.00K | 2.00K | 1.00K |
| Net Income | - | -30.45M | -33.78M | -10.13M | -2.80M |
| Diluted EPS | - | -7.55 | -4.65 | -0.36 | -0.06 |
| R&D Expense | - | 952.70K | 2.06M | 1.47M | 1.51M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Feb 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.29M | 464.00K | 3.73M | 2.15M |
| Current Assets | - | - | 391.00K | 365.00K | 3.62M | 2.10M |
| Cash & Equivalents | - | - | 271.00K | 47.00K | 172.00K | 585.00K |
| Inventory | - | - | - | - | - | - |
| Receivables | - | - | 19.00K | 152.00K | 213.00K | 495.00K |
| Total Liabilities | - | - | 27.65M | 13.91M | 19.68M | 5.12M |
| Current Liabilities | - | - | 26.10M | 13.84M | 19.23M | 4.83M |
| Long Term Debt | - | 1.55M | 1.50M | 465.00K | - | 220.00K |
| Total Debt | - | - | 26.24M | 5.09M | 8.76M | 570.00K |
| Total Equity | 0 | - | -26.36M | -13.44M | -15.95M | -2.96M |
| Shares Outstanding | - | - | 32.26M | 23.57M | 28.18M | 52.17M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -4.70M | -4.79M | -6.95M | -7.50M |
| Investing Cash Flow | - | -58.00K | -44.00K | -1.98M | 2.31M |
| Financing Cash Flow | - | 4.33M | 4.61M | 9.06M | 5.61M |
| Capital Expenditure | - | -58.00K | -44.00K | -51.00K | -13.00K |
| Free Cash Flow | - | -4.76M | -4.83M | -7.00M | -7.52M |
| Net Change in Cash | - | -428.00K | -224.00K | 125.00K | 413.00K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | -31.2% | -12.6% | -43.7% | -37.0% |
| Operating Margin % | - | -1,369.3% | -671.2% | -1,493.8% | -711.3% |
| Net Margin % | - | -2,641.0% | -3,308.5% | -1,575.3% | -206.1% |
| ROE % | - | 115.5% | 251.3% | 63.5% | 94.5% |
| ROCE % | - | 63.6% | 51.2% | 62.0% | 361.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ONMD
Millions of Medical Images From OneMedNet to Train a Foundational AI Model - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPUnRUQldaaldQSnFmRk4yakhHUHNUVDN4WHNnWFdkZDdGOTVyUjUxcnlNeG1vb0J6LWVicVZKNVhFT1AtSXd0eUhrdWo5LW96TzV1Nkp2cGg3WFZyVjNiYzRKcWgwUVQ0SUtvWHZmV0dDbW40ZFFGcVdfOTZxWklMU2ptR1hWaGtVeEZSa0…
ONMD|Onemednet Corp|Price:0.771|Chg%:+0.051 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBYWVFILXlVaWdiYU9VTk54MUNrSXBEMEdTcXdIdm5EWTg0cVM4dmFLMEJvTGRfcVRScUEtbVRmdW9PNWFZLTJFbUVwR2FsRXBkMU51TFlPWWtEakI4MFRuQlNQblZTcXhNajlIMW13?oc=5" target="_blank">ONMD|Onemednet Corp…
$ONMD stock is up 26% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOVGhJTHRfQk5DWTFsWk01RGNOYWRGM05Ca3pMNEJOSEVDLUZXdDA2TmN5M3hQVGgySFRjdFg1QXphTTBJOEN4QTdxdEZaZEpGQWo4dGlXbVdvNVhJOWZUbkJTUlJuVEMtTUFMRWVLNW5IU2x5aXA2YVBDLVdFd1o4R3U0OXA4clNiSzUzRT…
OneMedNet Corp Revenue Breakdown – NASDAQ:ONMD - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE1CakRKeUktdWp6NXFQcUNpUFpwN0xoWVJBMGJoa2RDV1NkUFl1NjhzSkVEM1lWcmFKdjFDbHU4OE55T3BzWUtpNTBmb2NjYVoxUmFuRHgwbl9TNEs4eGI3V3d4VDRrdTdfbEh5S2dnN0V5NnVSUHk0?oc=5" target="_blank">OneMedN…
OneMedNet Stock Rallies 33% After Hours: Here's Why - Sahm
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPR3EwRGRyQzlXYkVERWx6YjN2R2w0bnJhMzk3NTNWWVM0cHZ5X0M4c0VvVUwyLW9BZDBFanlwSHlFYTVWRW5IRjBJUlZwaUdTRnBoQ21SdmhZOGtTQVptWmx5bEh1MTJlSUh0aHpkQU9iaEROZzRWR21EVGdFc0VnM0h3VXRmWjYwVDQxcE…
Unusual volume stocks in Wednesday's session - ChartMill
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPS3F5MVJ2VkNLR3dhejhLeWlCRkdwdTdzNERXSV9vNHBVbTBWVGNPUWhLbkgzbHZ0UG92cTN3ZGdNUkJJbkcwaEZoVV9pMDg4aG0xZ1k2aVFPWExxNXJnbFlQajVNZERVaVhDVHpYMEZNU1I1NkxuVnZNSkpIZnduZUhseXZqMEZ4MUhvMk…
ONMD — Frequently Asked Questions
What is the current share price of ONMD?
As of 2026-08-05 17:25 PDT, ONMD trades at $0.65 on NASDAQ/NYSE. Its 52-week range is $0.45 to $3.14.
What is the market capitalisation of ONMD?
ONMD has a market capitalisation of $33.91M on NASDAQ/NYSE.
What is the P/E ratio of ONMD?
ONMD trades at a trailing price-to-earnings (P/E) ratio of -10.83. Its price-to-book (P/B) ratio is -11.44.
What is the return on equity (ROE) of ONMD?
ONMD has a return on equity (ROE) of 94.47%.
Is ONMD a good stock to buy?
This page provides a data-driven analysis of ONMD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.